Differences in Adverse Event Rates Found After Generic Commercialization of 3 Drugs
Immediate or delayed differences in adverse event rates were seen after generic commercialization of 3 antihypertensive drugs.
Generic Drugs
FDA Aims to Increase Number of Generic Drugs on the Market
The agency will now give priority reviews to new generic drugs until there are at least 3 available.
Mylan to Release Generic Version of EpiPen® In Continued Effort to Lower Costs
According to Mylan, the first generic version of EpiPen® will be distributed in several weeks in an attempt to further lower the costs of attaining this life-saving medication.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...